Endologix (NASDAQ: ELGX) reported Q2 EPS of ($0.18), $0.05 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $39.5 million versus the consensus estimate of $39.35 million.

For earnings history and earnings-related data on Endologix (ELGX) click here.